Text Size
18 studies found for:    " March 31, 2007":" April 30, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Active, not recruiting PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
Conditions: HIV-Dementia;   HIV-Associated Cognitive Motor Complex;   AIDS Encephalopathy;   AIDS Dementia Complex;   AIDS-Related Dementia Complex;   HIV Infections;   Healthy
Intervention: Drug: [11C]PBR28
2 Completed
Has Results 		Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   AIDS Virus;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus
Intervention: Drug: darunavir (DRV, TMC114)
3 Recruiting Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Metreleptin (Leptin)
4 Completed Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
Conditions: Tuberculosis;   Latent Tuberculosis Infection;   HIV Infections
Interventions: Drug: isoniazid;   Drug: Placebo
5 Recruiting Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
6 Completed HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-Infected Persons
Conditions: HIV Infections;   Herpes Simplex;   Sexually Transmitted Diseases
Interventions: Drug: Valacyclovir;   Drug: Matching Placebo
7 Completed Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: darunavir/ritonavir;   Drug: etravirine;   Drug: Optimized background regimen
8 Completed LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
Conditions: HIV Infections;   Diffuse Large B Cell Lymphoma
Interventions: Drug: R-CHOP;   Drug: Highly active antiretroviral therapy;   Drug: Central nervous system (CNS) prophylaxis;   Drug: Prophylaxis of opportunistic infections and support treatment
9 Completed Mechanisms of Lipodystrophy in HIV-Infected Pateints
Condition: HIV Infections
Intervention: Drug: Viracept versus Sustiva with stavudine and epivir
10 Completed The Treatment of Insomnia in Patients With HIV Disease
Conditions: HIV Infections;   Insomnia
Interventions: Drug: Doxepin;   Drug: Temazepam;   Drug: Placebo
11 Completed Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products
Condition: HIV Infections
Intervention: Drug: nevirapine, stavudine, lamivudine
12 Recruiting Subclinical Atherosclerosis in HIV-infected Patients
Conditions: HIV Infections;   Coronary Atherosclerosis
Intervention:
13 Completed HIV and Cardiovascular Risk
Conditions: HIV Infections;   Cardiovascular Disease
Intervention:
14 Completed Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Conditions: HIV Infections;   Meningitis
Interventions: Biological: Quadrivalent meningococcal conjugate vaccine (MCV4);   Biological: Quadrivalent meningococcal conjugate vaccine (MCV4) booster
15 Completed CMV Disease and IRIS in HIV-1 Infected Persons
Conditions: HIV Infections;   Cytomegalovirus
Intervention: Genetic: IE gene
16 Terminated ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Antiretroviral therapy
17 Completed Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Behavioral: Nevirapine from twice-a-day to once-a-day
18 Completed
Has Results 		Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
Condition: HIV
Intervention: Drug: TMC125, Darunavir; Ritonavir
To Top

† Indicates status has not been verified in more than two years